Elsevier Health announces the commercial launch of Sherpath AI, the most advanced AI solution in nursing and healthcare education

Elsevier Health, a global leader in health information and data analytics, today announced the commercial launch of Sherpath AI, the first and most advanced generative AI chat designed specifically for nursing students and faculty. Sherpath AI integrates Elsevier's trusted nursing education content, including multimedia videos, with advanced generative artificial intelligence (Gen AI), helping nurse educators and supporting students in navigating course materials, preparing for exams and transitioning into clinical practice.

As a groundbreaking conversational AI tool, Sherpath AI gives nursing students access to relevant personalized content at their fingertips and helps them achieve success in courses and exams. Students can ask questions with natural language in the same way they would speak to a trusted expert. The tool generates personalized responses sourced solely from Elsevier’s collection of evidence-based nursing content. Sherpath AI offers best-in-class, AI-enhanced features, and the most trusted nursing education content, including diverse multi-media tutorials like Osmosis for Nursing videos, across all Sherpath nursing courses. Citations and links to all content are included for easy access and illustrating accuracy and reliability. Interactive chat dialogue and personalized responses in the moment of learning create an individualized experience for students, while nurse educators are supported with tools to help with course preparation and teaching strategies.

The use of AI in healthcare is expected to grow considerably in the coming years. In Elsevier’s Clinician of the Future 2024: AI Edition report, 96% of clinicians said AI will help accelerate knowledge discovery and 88% felt AI would help increase work quality. This enthusiasm is mirrored in healthcare education, with the Clinician of the Future: Education Edition report finding that 62% of students are excited by the prospect of using generative AI tools in their education, a figure that continues to rise.

Brent Gordon, President, Nursing & Health Education, Elsevier Health said: “By expanding personalized learning, Sherpath AI can extend the reach of higher-education institutions to train more practice-ready nurses, improve program outcomes, and ultimately improve patient outcomes. We’re grateful to the institutions, students and educators who have worked closely with us during the development of Sherpath AI – their feedback and insight have been instrumental in getting us to today’s launch, and we are so excited to have this groundbreaking learning solution available across the US.”

Sherpath AI has been tested by more than 1,000 educators and more than tens of thousands of students at Arizona State University, Chamberlain University and Miami-Dade College, as well as other institutions across the US and the feedback has been overwhelmingly positive.

Judith F. Karshmer, PhD, PMHCNS-BC, FAAN, Dean & Professor, Arizona State University said: "At ASU, we are always looking for innovative ways to enhance student success and increase access to nursing education, and using Sherpath AI has shown the potential to help us to do both. Increasing capacity in nursing education is crucial to make sure we are able to address the shortfall of nurses in the US. By providing access to personalized, evidence-based content and engaging resources like Osmosis videos, Sherpath AI enhances both teaching and learning in ways we hadn't imagined. The ability to interact using natural language and receive instant, reliable answers has empowered our faculty and enriched our curriculum, while making complex concepts more accessible and understandable for our students."

Sherpath AI builds on Sherpath, Elsevier's market-leading teaching and learning courseware platform that supports hundreds of thousands of nursing students across the US, preparing them for both the National Council Licensure Examination (NCLEX) exam and clinical practice. The introduction of generative AI into its offerings aims to streamline access to trustworthy information, facilitating the education of the next generation of healthcare professionals. Elsevier’s content and technology are always underpinned by our Responsible AI Principles and Privacy Principles, created in collaboration with our communities.

To learn more about Sherpath AI, please visit our website by clicking here.

About Elsevier Health

For more than 140 years, Elsevier has supported the work of researchers and healthcare professionals by providing current, evidence-based information that can help empower students and clinicians to provide the best healthcare possible. Growing from our roots, Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for our customers across global health. We support health providers by providing accessible, trusted evidence-based information to take on the infodemic; prepare more future health professionals with effective tools and resources; provide insights that help clinicians improve patient outcomes; deliver healthcare that is truly inclusive; and supports a more personalized and localized healthcare experience.

Diversity and inclusion are the foundation of our innovation, and our teams are committed to creating education and practice solutions that reflect the diversity of our world. Elsevier Health is helping lay the groundwork for more equitable healthcare worldwide. We bring the same rigor to our digital information solutions as we do to our publishing, allowing us to offer knowledge and valuable analytics that help our users make breakthroughs and drive progress for the benefit of every patient.

エルゼビアについて エルゼビアは、科学情報と分析を牽引するグローバル企業として、研究者や医療従事者が社会の利益のために科学を進歩させ、医療成果を向上させることを支援しています。我々は信頼できるエビデンスベースのコンテンツと高度なAI対応デジタルテクノロジーに基づくソリューションにより、インサイトと重要な意思決定を促進することでこれを実現しています。

エルゼビアは、140 年以上にわたり研究および医療コミュニティの活動を支援してきました。全世界で 2,500 人以上の技術者を含む 9,500 人の従業員がおり、重要な職務における研究者や、図書館員、アカデミックリーダー、資金提供者、政府機関、R&D 関連企業、医師、看護師、将来の医療従事者や教育者を支援することに従事してきました。2,900 誌以上の科学ジャーナルと代表的な参考文献には、Cell Press、The Lancet、Gray's Anatomy など、各分野の主要なタイトルを含みます。 エルゼビア・ファウンデーション 新しいタブ／ウィンドウで開くと共に、開発途上国および世界中の科学、研究、医療分野におけるインクルージョン＆ダイバーシティ 新しいタブ／ウィンドウで開くを推進するため、支援コミュニティと連携して活動しています。 エルゼビアは、プロフェッショナルおよびビジネス顧客向けの情報に基づく分析および意思決定ツールのグローバルプロバイダーである RELX 新しいタブ／ウィンドウで開くグループの一部です。業務内容やデジタルソリューション、コンテンツ詳細については、 www.elsevier.com/ja-jpをご参照ください。